The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
A human multi-lineage hepatic organoid model for liver fibrosis
Open accessPublished version of a preprint
Abstract
To investigate the pathogenesis of a congenital form of hepatic fibrosis, human hepatic organoids were engineered to express the most common causative mutation for Autosomal Recessive Polycystic Kidney Disease (ARPKD). Here we show that these hepatic organoids develop the key features of ARPKD liver pathology (abnormal bile ducts and fibrosis) in only 21 days. The ARPKD mutation increases collagen abundance and thick collagen fiber production in hepatic organoids, which mirrors ARPKD liver tissue pathology. Transcriptomic and other analyses indicate that the ARPKD mutation generates cholangiocytes with increased TGFβ pathway activation, which are actively involved stimulating myofibroblasts to form collagen fibers. There is also an expansion of collagen-producing myofibroblasts with markedly increased PDGFRB protein expression and an activated STAT3 signaling pathway. Moreover, the transcriptome of ARPKD organoid myofibroblasts resemble those present in commonly occurring forms of liver fibrosis. PDGFRB pathway involvement was confirmed by the anti-fibrotic effect observed when ARPKD organoids were treated with PDGFRB inhibitors. Besides providing insight into the pathogenesis of congenital (and possibly acquired) forms of liver fibrosis, ARPKD organoids could also be used to test the anti-fibrotic efficacy of potential anti-fibrotic therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the organoid could recapitulate several liver diseases, including fatty liver disease, cirrhosis, and monogenic metabolic diseases (Guan et al., 2017;Wang et al., 2020;Guan et al., 2021).”
From Fast formation and maturation enhancement of human liver organoids using a liver-organoid-on-a-chip (2024) · cites this paper as Guan et al., 2021
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Spirlì, C., Locatelli, L., Morell, C. M., Fiorotto, R., Morton, S. D., Cadamuro, M., Fabris, L., & Strazzabosco, M. (2013) · Hepatology · doi:10.1002/hep.26554 · Cited by 49
RetractedSubramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
The Reactome pathway Knowledgebase
Fabregat, A., Sidiropoulos, K., Garapati, P., Gillespie, M., Hausmann, K., Haw, R., Jassal, B., Jupe, S., Korninger, F., McKay, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1351 · Cited by 5,605
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor
Davis, S., & Meltzer, P. S. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm254 · Cited by 3,303
Cited by
GSEApy: a comprehensive package for performing gene set enrichment analysis in Python
Fang, Z., Liu, X., & Peltz, G. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btac757 · Cited by 1,170
Self-citationOrganoids: The current status and biomedical applications
Yang, S., Hu, H., Kung, H., Zou, R., Dai, Y., Hu, Y., Wang, T., Lv, T., Yu, J., & Li, F. (2023) · MedComm · doi:10.1002/mco2.274 · Cited by 266
Accelerating scientific discovery with Co-Scientist
Gottweis, J., Weng, W.-H., Daryin, A., Tu, T., Sirkovic, P., Myaskovsky, A., Glowaty, G., Weissenberger, F., Orlandi, A., Popovici, D., et al. (2025) · arXiv · doi:10.48550/arxiv.2502.18864 · Cited by 158
“Nature | Vol 655 | 9 July 2026 | 495 for severe liver fibrosis 1,26,27 .”
Self-citationHuman pluripotent-stem-cell-derived organoids for drug discovery and evaluation
Vandana, J. J., Manrique, C., Lacko, L. A., & Chen, S. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.04.011 · Cited by 146
Self-citationRecent advances in lung organoid development and applications in disease modeling
Vazquez‐Armendariz, A. I., & Tata, P. R. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170500 · Cited by 142
Metadata
- Authors
- Guan, Y., Enejder, A., Wang, M., Fang, Z., Cui, L., Chen, S.-Y., Wang, J., Tan, Y., Wu, M., Chen, X., Johansson, P. K., Osman, I., Kunimoto, K., Russo, P., Heilshorn, S. C., & Peltz, G.
- Affiliations
- Stanford Medicine (US)
- Stanford University (US)
- Institute of Biomedical Sciences, Academia Sinica (TW)
- University of Pennsylvania (US)
- Corresponding author
- Peltz, Gary
- ORCID
- Venue
- Nature Communications
- Published
- 2021-10-22
- Volume
- 12
- Issue
- 1
- Pages
- 6138-6138
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC8536785
- OpenAlex
- W3205254301
- Cited by
- 149
- References
- 123
- Citations by year
- 2026: 26 · 2025: 45 · 2024: 37 · 2023: 22 · 2022: 16 · 2021: 3
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Foundation (2033302)
- Stanford Bio-X
- National Heart, Lung, and Blood Institute (R01HL142718)
- National Institute on Drug Abuse (5U01DA04439902)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK102182)
- National Institute of Biomedical Imaging and Bioengineering (R01EB027171)
- Division of Chemical, Bioengineering, Environmental, and Transport Systems
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- hepatic organoids, liver fibrosis, autosomal recessive polycystic kidney disease, congenital liver fibrosis, cholangiocytes, myofibroblasts, collagen fiber formation, TGF-beta signaling, PDGFRβ, STAT3 signaling, antifibrotic therapy, bile duct abnormalities, organoid models
- MeSH terms
- Bile Duct Diseases, Collagen, Epithelial Cells, Humans, Liver, Liver Cirrhosis, Models, Biological, Mutation, Organoids, Signal Transduction, Transforming Growth Factor beta, Polycystic Kidney, Autosomal Recessive, Receptor, Platelet-Derived Growth Factor beta, STAT3 Transcription Factor, Induced Pluripotent Stem Cells, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A human multi-lineage hepatic organoid model for liver fibrosis. https://app.cochat.ai/papers/10.1038/s41467-021-26410-9
- The paper
- Guan, Y., Enejder, A., Wang, M., Fang, Z., Cui, L., Chen, S.-Y., Wang, J., Tan, Y., Wu, M., Chen, X., Johansson, P. K., Osman, I., Kunimoto, K., Russo, P., Heilshorn, S. C., & Peltz, G. (2021). A human multi-lineage hepatic organoid model for liver fibrosis. Nature Communications. https://doi.org/10.1038/s41467-021-26410-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.